Hanmi Pharm. Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2018 - 2014
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2018 - 2014
Other Revenue	0	-	-0	-	-0	0	Upgrade
Revenue	1,566,245	1,490,887	1,331,547	1,203,186	1,075,854	1,113,650	Upgrade
Revenue Growth (YoY)	10.32%	11.97%	10.67%	11.84%	-3.39%	9.62%	Upgrade
Cost of Revenue	691,296	661,638	612,994	570,433	494,935	481,168	Upgrade
Gross Profit	874,949	829,249	718,553	632,752	580,918	632,482	Upgrade
Selling, General & Admin	425,835	426,789	406,146	361,309	319,555	334,316	Upgrade
Research & Development	193,284	181,769	154,317	146,027	212,387	194,288	Upgrade
Operating Expenses	614,925	604,364	564,657	507,336	531,942	528,604	Upgrade
Operating Income	260,024	224,885	153,896	125,416	48,976	103,878	Upgrade
Interest Expense	-25,856	-28,508	-22,647	-16,577	-24,867	-24,997	Upgrade
Interest & Investment Income	4,386	4,618	7,856	5,722	4,380	4,418	Upgrade
Earnings From Equity Investments	-10.99	1,258	-8,537	-4.02	-	-	Upgrade
Currency Exchange Gain (Loss)	-716.68	1,039	-2,641	13.07	3,461	23.29	Upgrade
Other Non Operating Income (Expenses)	-7,639	-4,571	-3,620	-9,277	-5,462	758.72	Upgrade
EBT Excluding Unusual Items	230,188	198,721	124,308	105,293	26,488	84,081	Upgrade
Gain (Loss) on Sale of Investments	4,132	2,630	47.09	-	-4,514	6,102	Upgrade
Gain (Loss) on Sale of Assets	46.39	1,769	451.65	-1,062	-313.72	-3,247	Upgrade
Asset Writedown	-8,313	-9,153	-3,794	-535.2	470.68	-3,666	Upgrade
Pretax Income	226,053	193,967	121,013	103,697	22,130	83,270	Upgrade
Income Tax Expense	44,434	28,601	19,454	22,218	4,841	19,402	Upgrade
Earnings From Continuing Operations	181,619	165,366	101,558	81,478	17,290	63,867	Upgrade
Minority Interest in Earnings	-20,954	-19,135	-18,766	-14,453	-5,330	-11,758	Upgrade
Net Income	160,664	146,231	82,792	67,025	11,959	52,110	Upgrade
Net Income to Common	160,664	146,231	82,792	67,025	11,959	52,110	Upgrade
Net Income Growth	22.35%	76.63%	23.52%	460.45%	-77.05%	109.35%	Upgrade
Shares Outstanding (Basic)	13	13	13	13	13	13	Upgrade
Shares Outstanding (Diluted)	13	13	13	13	13	13	Upgrade
Shares Change (YoY)	-0.08%	-0.09%	-0.12%	-0.11%	-0.09%	0.05%	Upgrade
EPS (Basic)	12667.32	11522.12	6517.33	5269.87	939.25	4088.90	Upgrade
EPS (Diluted)	12667.32	11522.12	6517.33	5269.87	939.25	4088.90	Upgrade
EPS Growth	22.45%	76.79%	23.67%	461.07%	-77.03%	109.24%	Upgrade
Free Cash Flow	187,881	189,186	131,890	181,974	109,719	-153,685	Upgrade
Free Cash Flow Per Share	14813.13	14906.67	10382.37	14307.73	8617.07	-12059.20	Upgrade
Dividend Per Share	740.196	490.196	-	-	-	-	Upgrade
Gross Margin	55.86%	55.62%	53.96%	52.59%	54.00%	56.79%	Upgrade
Operating Margin	16.60%	15.08%	11.56%	10.42%	4.55%	9.33%	Upgrade
Profit Margin	10.26%	9.81%	6.22%	5.57%	1.11%	4.68%	Upgrade
Free Cash Flow Margin	12.00%	12.69%	9.91%	15.12%	10.20%	-13.80%	Upgrade
EBITDA	357,562	323,339	250,738	214,502	110,315	159,290	Upgrade
EBITDA Margin	22.83%	21.69%	18.83%	17.83%	10.25%	14.30%	Upgrade
D&A For EBITDA	97,538	98,454	96,842	89,086	61,339	55,412	Upgrade
EBIT	260,024	224,885	153,896	125,416	48,976	103,878	Upgrade
EBIT Margin	16.60%	15.08%	11.56%	10.42%	4.55%	9.33%	Upgrade
Effective Tax Rate	19.66%	14.75%	16.08%	21.43%	21.87%	23.30%	Upgrade
Advertising Expenses	-	76,034	72,627	62,201	58,772	57,103	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.